HLA-Typed Cells
Accelerate Your Discovery with Characterized HLA-Typed Cell Products
In the context of the rapid advancements in immunotherapy, cell therapy, and precision medicine, human leukocyte antigen (HLA) typing has become an indispensable tool for researcher and developers. Our comprehensive portfolio of high-quality, rigorously characterized HLA-typed primary cells and cell lines provides you with the molecular precision needed to advance your research from bench to bedside with confidence.

Key Advantages of Our HLA-Typed Cells
Multiple Cell Types
- Peripheral Blood Mononuclear Cells (PBMCs): The standard for immunology assays.
- Isolated Immune Cell Subsets: Ready-to-use T cells, B cells, NK cells, monocytes, and dendritic cells.
- Antigen-Presenting Cells (APCs): Engineered cell lines (e.g., K562, CHO) or primary dendritic cells overexpressing specific HLA alleles.
- HLA-typed Cell Lines: Including Epstein-Barr Virus (EBV)-transformed B-lymphoblastoid cell lines (B-LCLs) for stable, reproducible antigen presentation.
Comprehensive Characterization and Uncompromising Quality
- Verified HLA Typing: Every batch undergoes high-resolution HLA typing for Class I (HLA-A, -B, -C) and Class II (HLA-DR, -DQ, -DP) alleles.
- Stringent QC: Beyond HLA, cells are tested for viability, sterility (mycoplasma, bacteria, fungi), and functionality (e.g., antigen presentation capabilities, cytokine response profiles where applicable).
Diverse and Well-Documented Donor Portfolio
- Diverse Genetic Representation: Access cells from donors with a wide array of common and well-documented HLA alleles and haplotypes, crucial for studies in diverse populations.
- Matched Sets Available: Obtain PBMCs, isolated immune cell subsets (CD4+ T cells, CD8+ T cells, Dendritic Cells, B cells), and fibroblasts from the same donor, enabling consistent, multi-faceted studies.
Expertise and Dedicated Support
- Ethically Sourced: All primary cells are obtained from fully consented donors and follow strict protocols. Detailed, anonymized donor metadata (age, sex, ethnicity) is provided.
- Scientific Collaboration: Our team includes immunologists ready to assist with experimental design and help you select the optimal HLA-typed cells for your model system.
Tailored Formats for Your Workflow
- Fresh and Cryopreserved Options: Choose high-viability cryopreserved vials for flexibility, or fresh cells for sensitive applications.
- Customized Validation: We offer custom functional validation to meet your specific assay needs, such as antigen-specific T-cell activation assays.
Key Applications of Our HLA-Typed Cells
- Vaccine Immunogenicity: Evaluate vaccine-induced T-cell responses across different HLA backgrounds.
- Cell Therapy Development: Assess the functionality of TCR-T or CAR-T cells against HLA-matched target cells.
- Immunotoxicity Screening: Predict drug and biologic-induced immune reactions (e.g., hypersensitivity) in pre-clinical models with relevant HLA contexts.
- Transplantation Research: Study alloreactivity, model graft-versus-host disease (GvHD), and develop strategies for donor-recipient matching.
- Autoimmune Disease Research: Explore disease mechanisms linked to specific HLA alleles (e.g., HLA-DRB104:01 in Type I diabetes, HLA-DRB115:01 in Multiple Sclerosis)
Our commitment to precision, quality, and scientific partnership ensures you receive reliable, well-characterized HLA-typed cells that are critical for:
- Enhancing the translational relevance of your preclinical data.
- Accelerating development timelines for cell therapies and vaccines.
- Generating robust, publication-quality data with high biological fidelity.
Contact our scientific support team today to discuss your project requirements and request a quote.